-
UPTAKE OF BIOSIMILARS TO INSULIN GLARGINE IN 2021-2025 IN THE UNITED STATES
Mar 18, 2026, 21:38 PM -
SYSTEMATIC REVIEW OF HEALTH ECONOMIC EVALUATIONS OF RARE DISEASES IN MEXICO
Mar 18, 2026, 21:38 PM -
DETECTING CONTRADICTIONS ACROSS CLINICAL, ECONOMIC, AND HTA DOCUMENTS USING AI OBJECTIVES
Mar 18, 2026, 21:38 PM -
A REAL-WORLD US COMMUNITY-BASED EVALUATION OF RECURRENCE AMONG INTERMEDIATE RISK NON-MUSCLE-INVASIVE BLADDER CANCER PATIENTS TREATED WITH BACILLUS CALMETTE-GUERIN
Mar 18, 2026, 21:38 PM -
ASSOCIATION BETWEEN GLP-1 RECEPTOR AGONIST USE AND INCIDENT ALCOHOL USE DISORDER AMONG PATIENTS WITH DIABETES: A REAL-WORLD EVIDENCE STUDY
Mar 18, 2026, 21:38 PM -
EXTERNAL CONTROL ARM FEASIBILITY ACROSS EXTERNAL DATA SOURCES IN ONCOLOGY: METHODOLOGICAL AND REGULATORY SCIENCE CONSIDERATIONS
Mar 18, 2026, 21:38 PM -
IMPLEMENTATION OF MANAGED-ENTRY AGREEMENTS IN HTA SUBMISSIONS: TYPES, USE-CASES, AND OPERATIONAL CONSIDERATIONS
Mar 18, 2026, 21:38 PM -
CHARACTERIZATION OF PATIENT-REPORTED OUTCOME UTILIZATION AND RESULTS REPORTED IN BREAST CANCER CLINICAL TRIALS REGISTERED ON CLINICALTRIALS.GOV (2020-2024)
Mar 18, 2026, 21:38 PM -
PERFORMANCE OF TRANSPORTABILITY METHODS UNDER EFFECT MEASURE MODIFIER OMISSION: A PLASMODE SIMULATION STUDY IN LUNG CANCER SCREENING
Mar 18, 2026, 21:38 PM -
POLYGENIC RISK SCORES IMPROVE NON-SMALL CELL LUNG CANCER PREDICTION IN REAL-WORLD US DATA
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF CONNECTED INJECTION DEVICE FOR PEDIATRIC GROWTH HORMONE DEFICIENCY IN ARGENTINA: A SCENARIO-BASED MICROSIMULATION ANALYSIS USING REAL-WORLD DATA
Mar 18, 2026, 21:38 PM -
ARE WE MAKING THE RIGHT COMPARISONS? EXAMINING THE WILLINGNESS-TO-PAY THRESHOLD UNDER DIFFERENT PERSPECTIVES
Mar 18, 2026, 21:38 PM -
HEALTH INEQUALITY AVERSION IN CHINA: PUBLIC AND DECISION-MAKER VIEWS
Mar 18, 2026, 21:38 PM -
SEX AND AGE-RELATED DIFFERENCES IN HEALTHCARE RESOURCE UTILIZATION AMONG PATIENTS WITH FRAGILE X SYNDROME (FXS): TRANSITION FROM CHILDHOOD TO ADULTHOOD
Mar 18, 2026, 21:38 PM -
GLP-1 RECEPTOR AGONIST-ASSOCIATED THROMBOCYTOPENIA: A NOVEL/EXTENSIVE PHARMACOVIGILANCE EVALUATION FROM SOUTHERN NETWORK ON ADVERSE REACTIONS (SONAR-AI)
Mar 18, 2026, 21:38 PM -
EVALUATION OF THE PCPA NEGOTIATION TIMELINE PROCESS FOR BRANDED NON ONCOLOGY DRUGS IN CANADA
Mar 18, 2026, 21:38 PM -
BUILDING HIGH-QUALITY, RESEARCH-GRADE MULTI-SOURCE MORTALITY DATABASES IN A TIMELY MANNER
Mar 18, 2026, 21:38 PM -
A U.S. BURDEN OF DISEASE PROJECTION MODEL FOR NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY, 2027-2035
Mar 18, 2026, 21:38 PM -
COST-EFFECTIVENESS OF PSILOCYBIN-ASSISTED THERAPY (PAT) FOR PATIENTS WITH TREATMENT-RESISTANT DEPRESSION
Mar 18, 2026, 21:38 PM -
INITIATION WITH GLP-1 RECEPTOR AGONISTS TREATMENT FOR OBESITY IN PATIENTS WITH MENTAL HEALTH CONDITIONS - A REAL WORLD DATA RETROSPECTIVE STUDY
Mar 18, 2026, 21:38 PM
